Trade Summary

2 months ago, Morrell Martha, serving as CHIEF MEDICAL OFFICER at Neuropace Inc (NPCE), sold 25,000 shares at $15.97 per share, for a total transaction value of $399,250.00. Following this transaction, Morrell Martha now holds 48,624 shares of NPCE.

This sale represents a 34.00% decrease in Morrell Martha's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, December 15, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 79 days after the trade was made.

Neuropace Inc operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.